Consultant Family Medicine oral assessment prep

Knowledge: He has type 2 diabetes with established atherosclerotic cardiovascular disease, chronic kidney disease stage G3a A3 and obesity, which makes him very high cardiovascular risk. Current guidelines recommend an SGLT2 inhibitor with proven kidney and cardiovascular benefit regardless of HbA1c, and a GLP-1 receptor agonist with proven cardiovascular benefit, which also helps weight. Albuminuria at this level calls for maximally tolerated renin-angiotensin blockade, and finerenone can add renal and cardiovascular benefit. His LDL target is below 1.4 mmol/L with at least a 50% reduction from baseline. Gliclazide carries hypoglycaemia risk that is more relevant during fasting and as renal function falls.

Management: Today I would add an SGLT2 inhibitor such as empagliflozin 10 mg, with sick-day advice to pause it during vomiting, dehydration or acute illness. I would increase atorvastatin to 80 mg and add ezetimibe if LDL remains above target after six weeks. I would titrate ramipril to 10 mg if potassium and creatinine allow, checking them within two weeks. I would start a GLP-1 receptor agonist such as semaglutide, titrating the dose gradually, and reduce or stop gliclazide as glycaemic control improves. I would consider finerenone once he is on maximal renin-angiotensin blockade with normal potassium. I would aim for blood pressure below 130/80 and set an individualised HbA1c target around 7%. I would arrange retinal and foot screening, dietitian support and Ramadan advice, and review him in three months.

Ethics and communication: I would agree priorities with him, because adding several medicines at once without his understanding damages adherence and trust. I would discuss costs and insurance coverage openly, since some agents may not be covered. I would document the shared decision and any treatment he declines, and avoid blaming him for previous control.

Reference: American Diabetes Association, Standards of Care in Diabetes; KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease; 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

Knowledge: Jaundice beyond 14 days in a term baby is prolonged and must be investigated rather than attributed to breastfeeding. Pale stools and dark urine point to conjugated hyperbilirubinaemia, and biliary atresia is the diagnosis that must not be missed because outcomes after the Kasai portoenterostomy are best when it is done early, ideally before about 45 to 60 days of age. A conjugated bilirubin above 25 micromol/L warrants urgent referral. Other causes include alpha-1 antitrypsin deficiency, infection, hypothyroidism, galactosaemia, Alagille syndrome and cystic fibrosis. Breast milk jaundice is unconjugated and never causes pale stools.

Management: I would send total and conjugated bilirubin today, with liver function tests, a full blood count and urine for infection. I would look for dysmorphism, a murmur, splenomegaly and bruising. I would not wait for results before calling the paediatric team, and I would refer the same day to a paediatric hepatology or gastroenterology service for ultrasound and further work-up. Because cholestasis causes vitamin K malabsorption, I would make sure he has had vitamin K and ask the team to check his clotting, given the risk of bleeding. I would advise stopping sun exposure, which does not treat this jaundice. I would document the referral, confirm by telephone that he will be seen within days, and give safety-net advice about bleeding or lethargy.

Ethics and communication: As he is a minor, consent is given by his guardian, and I would explain the concern honestly to both parents, including why speed matters, without causing unnecessary alarm. I would respect the grandmother's role in the family while gently correcting the misconception. I would document the advice given.

Reference: NICE Clinical Guideline CG98, Jaundice in Newborn Babies Under 28 Days; Fawaz R et al, Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of NASPGHAN and ESPGHAN (Journal of Pediatric Gastroenterology and Nutrition, 2017)

Knowledge: This is severe postnatal depression with suicidal ideation, and suicide is a leading cause of maternal death in the year after birth. I would screen for features of postpartum psychosis, such as confusion, mood swings, delusions or hallucinations, which would need emergency admission. Risk factors to explore include previous depression or self-harm, limited support, domestic abuse, substance use and access to means. Asking directly about suicide does not increase risk. Sertraline is generally preferred in breastfeeding because little passes into breast milk, but medicine alone is not enough at this severity.

Management: I would continue the conversation in private, take a full risk assessment, and judge her current risk as high enough to need same-day assessment by the perinatal or general psychiatry service. I would contact them while she is with me and agree who will take her there. With her consent, I would involve her husband or a trusted relative to stay with her and remove access to medicines. I would offer sertraline 50 mg once daily, starting lower if needed, and arrange psychological therapy. I would agree a written safety plan with crisis contacts. If she refused assessment and I judged the risk to be immediate, I would seek emergency psychiatric assessment. I would review her within a week, alert her obstetric and health visiting teams, and check that the baby's care is safe.

Ethics and communication: Confidentiality is important, but serious risk to her life justifies sharing necessary information with the psychiatric team and, if needed, with family. Involuntary admission is only possible under Federal Law No. 10 of 2019 on Mental Health when a mental disorder and serious risk are both present, so I would try to engage her voluntarily first. I would document my assessment and decisions in detail.

Reference: NICE Clinical Guideline CG192, Antenatal and Postnatal Mental Health: Clinical Management and Service Guidance; WHO mhGAP Intervention Guide, Version 2.0 (2016); Federal Law No. 10 of 2019 on Mental Health (UAE)

Knowledge: This is an acute inferior ST elevation myocardial infarction, and the hypotension with bradycardia suggests right ventricular involvement or a vagal response, both common with right coronary artery occlusion. Right ventricular infarction makes the patient preload-dependent, so nitrates and other vasodilators can cause profound hypotension. Primary percutaneous coronary intervention is the preferred reperfusion if it can be delivered within 120 minutes of diagnosis, which is achievable here. Complications to anticipate include complete heart block, ventricular fibrillation and cardiogenic shock. Aspirin reduces mortality and should be given at once unless allergic.

Management: I would call the ambulance immediately with a STEMI alert and send the ECG to the receiving cardiology team. I would not give glyceryl trinitrate because of the hypotension and likely right ventricular involvement. I would give aspirin 300 mg chewed, and leave the second antiplatelet and anticoagulant to the cardiology team unless they ask me to give them. I would record right-sided leads, looking for ST elevation in V4R. I would site an intravenous cannula, give a 250 mL saline bolus if the chest remains clear, and avoid oxygen unless saturation is below 90%. I would attach a defibrillator and have atropine available for symptomatic bradycardia. I would stay with him until the ambulance arrives, hand over in a structured way, and record times of symptom onset, ECG and treatment.

Ethics and communication: Consent is brief but should be real, explaining that this is a heart attack and that transfer is urgent. If he wants to drive himself or wait for family, I would explain the risk of death clearly and document his decision. Clinic governance includes regular checks of emergency drugs and defibrillators, and I would review any gaps afterwards.

Reference: Byrne RA et al, 2023 ESC Guidelines for the Management of Acute Coronary Syndromes (European Heart Journal, 2023); Resuscitation Council UK, Adult Advanced Life Support Guidelines (2021)

Knowledge: He has newly diagnosed HIV infection that needs antiretroviral therapy now, regardless of CD4 count. Early treatment improves his outcome and, once viral load is suppressed, prevents sexual transmission. His pregnant wife is at real risk, and if she is infected, treatment during pregnancy dramatically reduces transmission to the baby. HIV is a notifiable disease, so reporting to the public health authority is a legal duty that is separate from disclosure to family or employer. Baseline tests include viral load, resistance testing, hepatitis B and C, syphilis, tuberculosis screening and renal function.

Management: I would give the result in a private, unhurried consultation and check his understanding. I would refer him the same week to the HIV treatment service so that antiretroviral therapy can start promptly, ideally within seven days. I would notify the public health authority as required. I would explain that his wife's health and their baby's health depend on her being tested now, and offer him options: telling her himself with a time limit, telling her together with me, or provider-assisted notification. I would agree a short, specific timeframe and document it. If he still refused after repeated support, I would seek advice from the facility's ethics and legal team before any disclosure, and disclose only what is necessary to protect her. I would not share his result with his employer.

Ethics and communication: Confidentiality is protected under Federal Law No. 2 of 2019 on health data and is central to trust, but international ethical principles accept limited disclosure when a known person faces serious, avoidable harm. Notification under Federal Law No. 14 of 2014 is a separate legal duty. I would record each conversation, the options offered and the reasons for any decision.

Reference: WHO Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring (2021); WMA International Code of Medical Ethics (2022); Federal Law No. 14 of 2014 on the Prevention of Communicable Diseases (UAE)

Knowledge: This is confirmed iron deficiency anaemia in a man over 60 with weight loss, and gastrointestinal malignancy must be excluded even though NSAID use offers another explanation. Colorectal cancer, especially right-sided, and gastric cancer often present this way without bleeding symptoms. Guidelines recommend bidirectional endoscopy for iron deficiency anaemia in men and postmenopausal women, together with coeliac serology. Other causes include NSAID ulceration, angiodysplasia, coeliac disease and, rarely, urinary tract loss. Unexplained weight loss adds to the urgency and supports a suspected cancer pathway.

Management: I would take a focused history, including family history of colorectal cancer, diet and dysphagia, and examine the abdomen and rectum. I would send coeliac serology, renal function and liver tests, and consider a faecal immunochemical test, which should not delay endoscopy. I would refer urgently for gastroscopy and colonoscopy on the suspected cancer pathway. I would start oral iron once daily, or on alternate days to improve absorption and tolerance, and check haemoglobin in two to four weeks. I would advise him to stop ibuprofen and use alternatives for his knee pain. I would warn him to return urgently with black stools, vomiting blood or worsening breathlessness. I would track the referral and see him with the results.

Ethics and communication: He has the right to decline, but his refusal is only valid if it is informed, so I would explain clearly that iron alone may hide a cancer that is treatable if found early. I would explore his fears, which are often about discomfort, sedation or the result itself, and offer sedation, CT colonography as an alternative, or time to discuss with family. If he still declines, I would document the discussion, keep the door open and arrange review.

Reference: Snook J et al, British Society of Gastroenterology Guidelines for the Management of Iron Deficiency Anaemia in Adults (Gut, 2021); NICE Guideline NG12, Suspected Cancer: Recognition and Referral